International Real Estate Team
Our Real Estate team has a track record of advising businesses through strategic M&A and investment transactions including raising development capital, debt advisory, acquisitions, management buy-outs and partial or full exits to strategic financial or trade buyers. Our specialists offer unrivalled sector knowledge, working with leading industry players.
Our advisory expertise covers virtually all relevant sub-segments including: real estate development; consumer and leisure assets; healthcare facilities; real estate asset management; office, commercial and industrial assets; tourist accommodation facilities; and specialist apartments.
Our recent healthcare asset deals include:
Clearwater International advises Primonial REIM on the acquisition of Gecimed
Primonial REIM, one of the leaders in asset management for individuals in France, has acquired Gecina’s healthcare division, Gecimed portfolio.
Clearwater International advised Primonial REIM on the strategic and financial analysis of the portfolio, raising the equity and debt, the organisation of due diligences and negotiations with the seller.
“We are delighted with the funding package that we have secured which will allow us to continue expanding the Day Lewis pharmacy network towards our five year target of 400 pharmacies within the UK. Current market dynamics create a number of opportunities for Day Lewis and with the help of our funding partners we look forward to an exciting period of growth ahead. Clearwater International has been excellent throughout the process and we would recommend the debt advisory team to anybody looking to secure funding for their business.”
Sam Patel, Director at Day Lewis Group
Clearwater International advises chemist chain Day Lewis Group on €200M funding
Clearwater International has advised the shareholders of Day Lewis Group, one of the largest pharmacy chains in the UK and Europe, on securing €200m of investment from a number of banking partners.
The family-owned business currently owns 277 sites across the UK and is aiming to build up to more than 400 sites by 2021 alongside doubling its revenue, which was €335m in the year to 31 March 2015. The group is currently the fifth largest multi-pharmacy chain in England, employing 2,400 people, and plans to expand internationally within four years.
Clearwater International has advised C2S, owned by Bridgepoint, on its acquisition of Groupe Avenir Santé
Following the acquisition of Hôpital Privé d’Ambérieu in July 2015, Groupe C2S continues to accelerate its development with the acquisition of Avenir Santé. The group expands its geographical footprint by entering the Bourgogne-Franche-Comté region.
Avenir Santé operates 4 clinics with 200 doctors and 550 employees: the Paul Picquet clinic in Sens, the Polyclinique Val de Saône in Mâcon, the Polyclinique du Parc Drevon in Dijon and the Clinique du Jura in Lons-le-Saunier. The group has been owned by Montefiore Investment since 2011.
Clearwater International advises the family shareholders of Hôpital Privé d’Evry on the disposal of the group to Almaviva Santé
Historical and reference player on its healthcare area, Hôpital Privé dEvry operates 2 complementary Evry-located hospitalisation facilities; a MSO clinic and a rehabilitation clinic, representing over 210 beds and places, completed by a multidisciplinary consultation centre.
Specialising in orthopaedic, digestive, ophthalmologic and ENT surgery and in obstetrics, Clinique de lEssonne (CDE) operates more than 120 beds and greets over 12,000 MSO-patients each year.